Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Actinogen Medical ( (AU:ACW) ) has provided an update.
Actinogen Medical Limited has announced the quotation of 251,050 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of December 5, 2025. This move marks a significant step for the company, potentially enhancing its market presence and providing additional capital for its operations, which could positively impact its stakeholders.
The most recent analyst rating on (AU:ACW) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapies for neurological conditions.
Average Trading Volume: 4,182,301
Technical Sentiment Signal: Buy
Current Market Cap: A$175M
For an in-depth examination of ACW stock, go to TipRanks’ Overview page.